Owens & Minor (OMI) Upgraded to “Hold” at Zacks Investment Research
According to Zacks, “Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor’s customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. “
A number of other research firms have also recently issued reports on OMI. ValuEngine upgraded Owens & Minor from a “sell” rating to a “hold” rating in a report on Saturday, February 2nd. Barclays reiterated a “sell” rating and issued a $5.00 price objective on shares of Owens & Minor in a report on Thursday, February 21st. Jefferies Financial Group reiterated a “hold” rating and issued a $7.00 price objective on shares of Owens & Minor in a report on Thursday, February 21st. Finally, Bank of America reiterated a “neutral” rating and issued a $4.50 price objective (down from $7.00) on shares of Owens & Minor in a report on Wednesday, April 10th. Two analysts have rated the stock with a sell rating and five have issued a hold rating to the company. Owens & Minor presently has a consensus rating of “Hold” and a consensus price target of $6.21.
Owens & Minor (NYSE:OMI) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). Owens & Minor had a positive return on equity of 6.92% and a negative net margin of 4.63%. The firm had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.45 billion. During the same quarter in the previous year, the company posted $0.43 earnings per share. Owens & Minor’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, equities research analysts expect that Owens & Minor will post 0.58 EPS for the current year.
A number of hedge funds have recently modified their holdings of OMI. Bank of New York Mellon Corp raised its stake in shares of Owens & Minor by 3.8% in the third quarter. Bank of New York Mellon Corp now owns 1,431,700 shares of the company’s stock valued at $23,651,000 after buying an additional 52,294 shares during the period. Teachers Advisors LLC raised its stake in shares of Owens & Minor by 29.9% during the 3rd quarter. Teachers Advisors LLC now owns 152,468 shares of the company’s stock valued at $2,519,000 after purchasing an additional 35,108 shares during the period. Vanguard Group Inc. raised its stake in shares of Owens & Minor by 0.5% during the 3rd quarter. Vanguard Group Inc. now owns 6,381,521 shares of the company’s stock valued at $105,422,000 after purchasing an additional 33,197 shares during the period. Strs Ohio raised its stake in shares of Owens & Minor by 459.1% during the 4th quarter. Strs Ohio now owns 91,700 shares of the company’s stock valued at $580,000 after purchasing an additional 75,300 shares during the period. Finally, Inlet Private Wealth LLC bought a new stake in shares of Owens & Minor during the 4th quarter valued at $1,076,000. Institutional investors own 94.02% of the company’s stock.
About Owens & Minor
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
Further Reading: Why is insider trading harmful?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.